These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 22486731)
1. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting. De Silva AP; Nandasiri SD; Hewavisenthi J; Manamperi A; Ariyasinghe MP; Dassanayake AS; Jewell DP; de Silva HJ Scand J Gastroenterol; 2012 Jun; 47(6):619-24. PubMed ID: 22486731 [TBL] [Abstract][Full Text] [Related]
2. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860 [TBL] [Abstract][Full Text] [Related]
3. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815 [TBL] [Abstract][Full Text] [Related]
4. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Bertiaux-Vandaële N; Youmba SB; Belmonte L; Lecleire S; Antonietti M; Gourcerol G; Leroi AM; Déchelotte P; Ménard JF; Ducrotté P; Coëffier M Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894 [TBL] [Abstract][Full Text] [Related]
6. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012 [TBL] [Abstract][Full Text] [Related]
7. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712 [TBL] [Abstract][Full Text] [Related]
8. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome. Willot S; Gauthier C; Patey N; Faure C Neurogastroenterol Motil; 2012 Aug; 24(8):734-9, e347. PubMed ID: 22625872 [TBL] [Abstract][Full Text] [Related]
9. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556 [TBL] [Abstract][Full Text] [Related]
10. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165 [TBL] [Abstract][Full Text] [Related]
11. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome]. Kong WM; Gong J; Dong L; Xu JR Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1345-7. PubMed ID: 17884774 [TBL] [Abstract][Full Text] [Related]
12. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702 [TBL] [Abstract][Full Text] [Related]
13. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome. Zhang Y; Qin G; Liu DR; Wang Y; Yao SK World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915 [TBL] [Abstract][Full Text] [Related]
14. [Relationship between intestinal mucosal inflammation and mental disorders in patients with irritable bowel syndrome]. Hao JX; Han M; Duan LP; Han YJ; Ge Y; Huang YQ Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(32):2247-51. PubMed ID: 23158482 [TBL] [Abstract][Full Text] [Related]
15. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Dunlop SP; Hebden J; Campbell E; Naesdal J; Olbe L; Perkins AC; Spiller RC Am J Gastroenterol; 2006 Jun; 101(6):1288-94. PubMed ID: 16771951 [TBL] [Abstract][Full Text] [Related]
16. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797 [TBL] [Abstract][Full Text] [Related]
17. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients. Doyle LA; Sepehr GJ; Hamilton MJ; Akin C; Castells MC; Hornick JL Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605 [TBL] [Abstract][Full Text] [Related]
18. [Phenotypic analysis of Th cells in colon and peripheral blood in patients with irritable bowel syndrome]. Fu Y; Tong JJ; Pan Q; Wang WF; Zou KF; Qian W; Hou XH Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2120-3. PubMed ID: 20058616 [TBL] [Abstract][Full Text] [Related]
19. [Changes in tight junction of intestinal mucosa in patients with irritable bowel syndrome: a study with tracing electron microscope]. Kong WM; Gong J; Dong L; Chen MX Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1167-70, 1172. PubMed ID: 17715017 [TBL] [Abstract][Full Text] [Related]
20. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. Coëffier M; Gloro R; Boukhettala N; Aziz M; Lecleire S; Vandaele N; Antonietti M; Savoye G; Bôle-Feysot C; Déchelotte P; Reimund JM; Ducrotté P Am J Gastroenterol; 2010 May; 105(5):1181-8. PubMed ID: 19997094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]